Crossmark

Evaluation of the metabolic activity, angiogenic impacts, and GSK-3β signaling of the synthetic cannabinoid MMB-2201 on human cerebral microvascular endothelial cells

Crossref DOI link: https://doi.org/10.1186/s42238-024-00255-7

Published Online: 2024-12-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

AL-Eitan, Laith Naser https://orcid.org/0000-0003-0064-0190
Alahmad, Saif Zuhair https://orcid.org/0000-0002-8962-6733
Ajeen, Sufyan Ali https://orcid.org/0000-0001-9396-5714
Altawil, Ahmad Younis https://orcid.org/0009-0003-8278-6384
Khair, Iliya Yacoub https://orcid.org/0000-0003-1782-9037
Kharmah, Hana Salah Abu https://orcid.org/0000-0001-5094-6329
Alghamdi, Mansour Abdullah https://orcid.org/0000-0002-6613-1498
Funding

Funding for this research was provided by:

Deanship of Research, Jordan University of Science and Technology (513/2020)

The Scientific Research Support Fund (SRSF) at The Jordanian Ministry of Higher Education (MPH/1/43/2017)
License Information

Text and Data Mining valid from 2024-12-20

Version of Record valid from 2024-12-20
More Information

Article History

Received: 14 July 2024

Accepted: 4 December 2024

First Online: 20 December 2024

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below